PullBack Fishing Symmetrical TriangleSymmetrical Triangles are a continuation pattern and can break either way..
Earnings 2-4 AMC
Not a recommendation
Keeping an eye on it tho (o:
VRTX trade ideas
$VRTX - Nice bear flagBearish pattern is emerging. Selling volume is still weak, but flush to 195 and 180 (VWAP) is likely
Breakout of resistancewont be long before the stock breaks above the $237 resistance as it trades in the upward channel
Could vrtx fill the gap?VRTX has been inching closer to breaking out of its range state. With Biotech making new highs the stock should have flow tailwinds and any suppression of volatility in the market should be a positive.
VRTX - long term play - solid fundamentals - Ark has just boughtVRTX - long term play - solid fundamentals - Ark has just bought
VRTX Gap Fill Play - Bullish- Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for treating cystic fibrosis.
- Target Price: $292.00 by CreditSuisse Oct 29, 2020 with multiple buy ratings by different analysts
- Recent Drop from failed study of VX-814 for patients with ALPHA-1 ANTITRYPSIN DEFICIENCY, but still one more study going in same target area and fundamentals of other revenue makers intact.
- Price entering the gap from that day's drop.
- Trends of more insider buying since the drop and stock buy backs. Signaling that the stock is undervalued.
- Bull flagging right under the gap.
Key Level: $232.41
Price Target: 269.93
ATR: $6.60
Play:
Bullish Gap Fill
Buy the Dip under the key level to scale in
Use $232.41 as inflection point.
Look for breakout with increased volume
Price Target: 270
Under $224 will invalidate
NASDAQ: VRTX / Vertex Pharmaceuticals IncorporatedHi.
I'm OrdinariusTrader.
I'm The Best Trader In The World.
If you want new shares, you know what to do.
Like and follow.
Which way we'r going , place your view with reasoning .Which way we'r going , place your view with reasoning . Lets hear from you guys , lets draw charts!
VERTEX picking upvertex lays on support 2 on postmarket
according to vrtx/spx channel, it can decline on 20 percent, so waiting on support 2 to pickup
Pull Back/Bottom Fishing Rising Wedge/Head and Shoulders H&S with a bearishrising narrowing wedge = TROUBLE
Bad combo
OUCH!
From looking at monthly and weekly candles, looks like this one may pull back a bit more
NV is very high on this one. Short interest fairly low considering. I guess the shorties did not catch this pattern on time. Short interest was up 12% today
No recommendation/just an observation
VRTX Buy at 285.67 with profit taking at 382.73VRTX is basing below the 10WMA and that is a big negative. The positive of this is that the volume action below the 10WMA is drying up, which means that there is a quiet consolidation period that is going on. If this consolidation period starts to show price action that shoots above the 10WMA then there is a potential buy. The 1st buy might be at 285.67 with the 2nd one at 306.18 assuming they are both confirmed by high volume action. VRTX can break out at any point because the minimum 5 weeks for a base has been met. Fundamentals are great as shown below.
Yearly EPS
2018: 4.08
2019: 5.33
2020: 9.72
2021: 11.26
Quarterly Sales
Sep-19: +21%
Dec-19: +62%
Mar-20: +76%
Jun-20: +62%
VRTX hourly - pull back in strengthhoping to see strength resume after pullback. stop below aug-31 lows
$VRTX wound up tight. Biotechs hot.Going with fundamentally strong companies with opportunistic chart patterns.
VERTEX PHARMACEUTICAL: UNLIMITED RISE AFTER 60 RANGE POINTS!!
New agreements with Germany and England for new medicines and medical research developments.
We combine the stochastic with the 125 and 40 period moving lines, expect a crossover of both lines within the range and if it is coincident with the stochastic crossing the oversold line up, then we release the long. We can work stretches of 60 points.
VRTX : SLINGSHOT BREAKOUT +125% earnings on previous quarter, average growth of +30% previous quarters
+76% revenue growth, accelerating from previous quarters
+44% net margins, expanding from +30%
Positive earnings revisions
VRTX : SLINGSHOT125% earnings growth past quarter, +30% previous quarters
+76% revenue growth past quarter, accelerating from the precious quarters
Positive earnings revisions
